View More
Pioneering Stem Cell Solutions
for Intractable Diseases
We aim to provide fundamental solutions to Treat intractable neurological diseases using
innovative iPSC-based cell&gene therapy and drug discovery approaches.
innovative iPSC-based cell&gene therapy and drug discovery approaches.
Innovation for
regeneration,
new hope for life
IPS Bio leads the field of stem cell research and regenerative medicine, continuously striving for
innovation and research to bring the treatments of the future to life today
PIPELINE
Shaping the Future with
Innovative Stem Cell Therapy
Innovative Stem Cell Therapy
We are expanding the pipeline further
through continuous research
iPB01
Stem Cell Therapy
Huntington's Disease
iPB02
Stem Cell Therapy
Stroke (Chronic)
iPB03
Stem Cell Therapy
Alzheimer's Disease
iPB04
Small Molecules
Huntington's Disease
iPB05
Small Molecules
Alzheimer's Disease
MERIT
Shaping the Future with
Innovative Stem Cell Therapy
Innovative Stem Cell Therapy
We will do our best to realize the hope of improving the quality of life and extending life
- Funding
- Raised 8 billion KRW in Series A funding
- Developing
Treatments - Developing treatments for Huntington's and neurological diseases
- Signed
an MOU - Signed an MOU for collaborative research with CHA University and Toolgen
- Formed
Partnership - Formed a partnership for collaborative research with the Japan CiRA Foundation
Copyright © iPS Bio, Inc. All Rights Reserved.
- - Address.
- Suites 406-409, Pangyo Innovation Lab, 80 Beon-gil 11, Geumto-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do 13453, Republic of Korea
- - Tel.
- +82-31-707-6733
- - Fax.
- +82-31-707-6734